Analysis

$600671 analysis on 6ix - valuation, growth, dividend & more for Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class A

Track Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class A (600671) on 6ix - releases, events, and the audience already following the stock.

website$600671/analysis/600671

Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class A

Run a Simply Wall St-style analysis on $600671 (Hangzhou Tianmushan Pharmaceutical Enterprise Co Ltd Class A) - valuation, growth, past performance, dividend...

View the company page